Prashant Patel qualified in 1993 from India and then trained to qualify as a General Surgeon with special interest in pelvic surgery. He pursued a career in General Surgery in the UK since 1999 until entering cancer research in 2002. He was awarded a PhD from the University of Birmingham whilst training as a Urologist. His research explored gene and immunotherapy for prostate cancer. 

He travelled to Perth (2010), Australia to complete a fellowship in urological cancer surgery where he had exposure to laparoscopic and robotic surgery. He has professional registration with UK, India, USA, Australia as well has the Fellowship with European Board of Urology.

He was appointed as a Senior Lecturer in Urology at the University of Birmingham and Consultant Urological Surgeon at QE Hospital (UHB), Birmingham (2010) to pursue a joint career in academic and clinical urology. He is an accredited trainer and educational supervisor by the General Medical Council. He regularly lectures at the University of Birmingham and is a tutor for post-graduate programs. He is on the committee of National Urology Trainee selection since 2011. He is on the teaching faculty at the British Association of Urological Surgeons for the FRCS (Urology) Examinations.

His international profile includes panellist and Chair on Bladder Cancer at the European Urology Annual Meetings over several years, Member of the Scientific Evaluation Committee for Translational Cancer Research at the French National Cancer Institute, and Frontiers Guest Associate Editor in Genitourinary Oncology.

He is on the board of directors for the ManVan Charity and regularly participates in fundraising and raising awareness for Prostate, Bladder and Testicular cancers at several charity and BAME events.

His academic interests are to explore molecular markers in bladder cancer, immunotherapeutic approaches in all urological cancers and informatics. He is extensively published with >100 peer reviewed articles in journals and book chapters.

 He is the Chief Investigator on Gene therapy clinical trial and is also a Principal investigator in several prostate and bladder cancer studies. He is a grant holder of several trials and studies. His research interests are also outside the field of Urology involving large datasets (informatics) where his team explore disease and outcome trends. This area of research has also led to recommendations in national guidance. 

Prashant is also the theme lead in Clinical Research and Epidemiology for the Bladder Cancer Research Centre in the Institute of Cancer and Genomic Sciences. He is the Head of Department (Clinical Service Lead) since 2019 at the University Hospitals Birmingham (QE Hospital, Heartlands, Good Hope and Solihull Hospitals) which covers a population of >2 million Brummies.

He keeps himself in check by keeping fit through endurance training involving: cycling, eating well, meditation and has summited several high altitude mountain peaks in Europe, Russia, Africa, South America, Nepal and India.